Contact
Please use this form to send email to PR contact of this press release:
Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
TO:
Please use this form to send email to PR contact of this press release:
Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
TO: